Skip to content
GLP-1 Scorecard
Menu
Graded #284

LumiMeds

Telehealth provider with flat-rate compounded GLP-1 pricing on a 3-month plan.

Visit LumiMedsWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$133/mo (starting dose, compounded)
Tirzepatide
$133/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Weigh LumiMeds against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because LumiMeds dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value77/100
Dose & formulation64/100
Clinical oversight55/100
Labs & monitoring53/100
Fulfillment65/100
Contract terms55/100

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
  • FDA issued Lumimeds a warning letter in September 2025; the letter is public in FDA's warning-letter database

Bottom line — Grade C

Best for: Shoppers who want mainstream telehealth GLP-1 access.

Ranked #284 of 544 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

FDAWarning letter issued to Lumimeds in September 2025. See the FDA warning-letter database.

Closest here

The rankings grading nearest LumiMeds — the realistic shortlist.

The 20 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect LumiMeds's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on LumiMeds's site. Not medical advice; see our disclosure.

← Back to the scorecard